Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66,903 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
False-Positive Circulating Tumor DNA Results Do Not Explain Lack of Efficacy for PARP Inhibitors in Patients With Castration-Resistant Prostate Cancer Harboring ATM and CHEK2 Mutations.
Fallah J, Xu J, Joeng HK, Weinstock C, Heiss BL, Maguire WF, Gao X, Cheng J, Chang E, Agrawal S, Fiero MH, Pazdur R, Kluetz PG, Amiri-Kordestani L, Suzman DL. Fallah J, et al. Among authors: xu j. JCO Precis Oncol. 2024 Aug;8:e2400354. doi: 10.1200/PO.24.00354. JCO Precis Oncol. 2024. PMID: 39208375
Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled Analysis.
Fallah J, Xu J, Weinstock C, Gao X, Heiss BL, Maguire WF, Chang E, Agrawal S, Tang S, Amiri-Kordestani L, Pazdur R, Kluetz PG, Suzman DL. Fallah J, et al. Among authors: xu j. J Clin Oncol. 2024 May 10;42(14):1687-1698. doi: 10.1200/JCO.23.02105. Epub 2024 Mar 14. J Clin Oncol. 2024. PMID: 38484203
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.
Fallah J, Xu J, Weinstock C, Brave MH, Bloomquist E, Fiero MH, Schaefer T, Pathak A, Abukhdeir A, Bhatnagar V, Chiu HJ, Ricks T, John C, Hamed S, Lee C, Pierce WF, Kalavar S, Philip R, Tang S, Amiri-Kordestani L, Pazdur R, Kluetz PG, Suzman D. Fallah J, et al. Among authors: xu j. J Clin Oncol. 2024 Feb 10;42(5):605-613. doi: 10.1200/JCO.23.01868. Epub 2023 Dec 21. J Clin Oncol. 2024. PMID: 38127780 Clinical Trial.
Statistical Methods for Clinical Study Site Selection.
Xu J, Huang L, Yao Z, Xu Z, Zalkikar J, Tiwari R. Xu J, et al. Among authors: xu z. Ther Innov Regul Sci. 2020 Jan;54(1):211-219. doi: 10.1007/s43441-019-00047-9. Epub 2020 Jan 6. Ther Innov Regul Sci. 2020. PMID: 32008238
66,903 results
You have reached the last available page of results. Please see the User Guide for more information.